nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—CHRM3—ureter—urinary bladder cancer	0.0867	0.24	CbGeAlD
Tiotropium—CHRM3—muscle of abdomen—urinary bladder cancer	0.0624	0.173	CbGeAlD
Tiotropium—CYP3A4—urine—urinary bladder cancer	0.0155	0.0428	CbGeAlD
Tiotropium—CYP2D6—urine—urinary bladder cancer	0.0152	0.0422	CbGeAlD
Tiotropium—CHRM5—epithelium—urinary bladder cancer	0.0133	0.0368	CbGeAlD
Tiotropium—SLC22A4—prostate gland—urinary bladder cancer	0.0128	0.0354	CbGeAlD
Tiotropium—CHRM2—prostate gland—urinary bladder cancer	0.0124	0.0344	CbGeAlD
Tiotropium—CHRM1—prostate gland—urinary bladder cancer	0.0113	0.0313	CbGeAlD
Tiotropium—SLC22A4—seminal vesicle—urinary bladder cancer	0.0108	0.03	CbGeAlD
Tiotropium—CHRM3—prostate gland—urinary bladder cancer	0.0101	0.028	CbGeAlD
Tiotropium—SLC22A4—renal system—urinary bladder cancer	0.00873	0.0242	CbGeAlD
Tiotropium—SLC22A5—prostate gland—urinary bladder cancer	0.00847	0.0235	CbGeAlD
Tiotropium—SLC22A5—seminal vesicle—urinary bladder cancer	0.00717	0.0198	CbGeAlD
Tiotropium—CHRM3—smooth muscle tissue—urinary bladder cancer	0.00716	0.0198	CbGeAlD
Tiotropium—SLC22A4—female reproductive system—urinary bladder cancer	0.00699	0.0193	CbGeAlD
Tiotropium—CHRM3—renal system—urinary bladder cancer	0.00689	0.0191	CbGeAlD
Tiotropium—CHRM3—urethra—urinary bladder cancer	0.00677	0.0187	CbGeAlD
Tiotropium—SLC22A4—vagina—urinary bladder cancer	0.00632	0.0175	CbGeAlD
Tiotropium—CHRM1—female reproductive system—urinary bladder cancer	0.00617	0.0171	CbGeAlD
Tiotropium—SLC22A5—renal system—urinary bladder cancer	0.00578	0.016	CbGeAlD
Tiotropium—SLC22A5—urethra—urinary bladder cancer	0.00567	0.0157	CbGeAlD
Tiotropium—CHRM3—female reproductive system—urinary bladder cancer	0.00552	0.0153	CbGeAlD
Tiotropium—SLC22A5—female reproductive system—urinary bladder cancer	0.00463	0.0128	CbGeAlD
Tiotropium—SLC22A5—vagina—urinary bladder cancer	0.00418	0.0116	CbGeAlD
Tiotropium—SLC22A4—lymph node—urinary bladder cancer	0.00409	0.0113	CbGeAlD
Tiotropium—CYP3A4—renal system—urinary bladder cancer	0.00379	0.0105	CbGeAlD
Tiotropium—CYP2D6—renal system—urinary bladder cancer	0.00373	0.0103	CbGeAlD
Tiotropium—CYP3A4—female reproductive system—urinary bladder cancer	0.00303	0.00839	CbGeAlD
Tiotropium—CYP2D6—female reproductive system—urinary bladder cancer	0.00299	0.00826	CbGeAlD
Tiotropium—SLC22A5—lymph node—urinary bladder cancer	0.00271	0.00749	CbGeAlD
Tiotropium—Myalgia—Fluorouracil—urinary bladder cancer	0.00146	0.00228	CcSEcCtD
Tiotropium—Chest pain—Fluorouracil—urinary bladder cancer	0.00146	0.00228	CcSEcCtD
Tiotropium—Constipation—Thiotepa—urinary bladder cancer	0.00144	0.00226	CcSEcCtD
Tiotropium—Back pain—Etoposide—urinary bladder cancer	0.00144	0.00225	CcSEcCtD
Tiotropium—Oedema—Gemcitabine—urinary bladder cancer	0.00142	0.00222	CcSEcCtD
Tiotropium—Infection—Gemcitabine—urinary bladder cancer	0.00141	0.00221	CcSEcCtD
Tiotropium—Oedema—Fluorouracil—urinary bladder cancer	0.0014	0.00219	CcSEcCtD
Tiotropium—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00139	0.00218	CcSEcCtD
Tiotropium—Infection—Fluorouracil—urinary bladder cancer	0.00139	0.00217	CcSEcCtD
Tiotropium—Pain in extremity—Epirubicin—urinary bladder cancer	0.00138	0.00216	CcSEcCtD
Tiotropium—Myalgia—Cisplatin—urinary bladder cancer	0.00138	0.00216	CcSEcCtD
Tiotropium—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00138	0.00216	CcSEcCtD
Tiotropium—Skin disorder—Gemcitabine—urinary bladder cancer	0.00138	0.00216	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00137	0.00215	CcSEcCtD
Tiotropium—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00137	0.00214	CcSEcCtD
Tiotropium—Tachycardia—Fluorouracil—urinary bladder cancer	0.00136	0.00213	CcSEcCtD
Tiotropium—Urticaria—Thiotepa—urinary bladder cancer	0.00134	0.0021	CcSEcCtD
Tiotropium—Abdominal pain—Thiotepa—urinary bladder cancer	0.00133	0.00209	CcSEcCtD
Tiotropium—Oedema—Cisplatin—urinary bladder cancer	0.00132	0.00207	CcSEcCtD
Tiotropium—Infection—Cisplatin—urinary bladder cancer	0.00131	0.00206	CcSEcCtD
Tiotropium—Loss of consciousness—Etoposide—urinary bladder cancer	0.00131	0.00204	CcSEcCtD
Tiotropium—Nervous system disorder—Cisplatin—urinary bladder cancer	0.0013	0.00203	CcSEcCtD
Tiotropium—Cough—Etoposide—urinary bladder cancer	0.0013	0.00203	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00129	0.00203	CcSEcCtD
Tiotropium—Tachycardia—Cisplatin—urinary bladder cancer	0.00129	0.00202	CcSEcCtD
Tiotropium—Dehydration—Epirubicin—urinary bladder cancer	0.00129	0.00201	CcSEcCtD
Tiotropium—Skin disorder—Cisplatin—urinary bladder cancer	0.00129	0.00201	CcSEcCtD
Tiotropium—Insomnia—Gemcitabine—urinary bladder cancer	0.00128	0.00201	CcSEcCtD
Tiotropium—Hypertension—Etoposide—urinary bladder cancer	0.00128	0.00201	CcSEcCtD
Tiotropium—Pain in extremity—Doxorubicin—urinary bladder cancer	0.00128	0.002	CcSEcCtD
Tiotropium—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00127	0.002	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00127	0.00199	CcSEcCtD
Tiotropium—Dry skin—Epirubicin—urinary bladder cancer	0.00127	0.00198	CcSEcCtD
Tiotropium—Chest pain—Etoposide—urinary bladder cancer	0.00126	0.00198	CcSEcCtD
Tiotropium—Insomnia—Fluorouracil—urinary bladder cancer	0.00126	0.00198	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00126	0.00197	CcSEcCtD
Tiotropium—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00125	0.00196	CcSEcCtD
Tiotropium—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00124	0.00195	CcSEcCtD
Tiotropium—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00123	0.00192	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00123	0.00192	CcSEcCtD
Tiotropium—Constipation—Gemcitabine—urinary bladder cancer	0.00121	0.0019	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00121	0.00189	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00121	0.00189	CcSEcCtD
Tiotropium—Infection—Etoposide—urinary bladder cancer	0.0012	0.00189	CcSEcCtD
Tiotropium—Dysphagia—Epirubicin—urinary bladder cancer	0.00119	0.00187	CcSEcCtD
Tiotropium—Dysuria—Methotrexate—urinary bladder cancer	0.00119	0.00187	CcSEcCtD
Tiotropium—Pruritus—Thiotepa—urinary bladder cancer	0.00119	0.00187	CcSEcCtD
Tiotropium—Dehydration—Doxorubicin—urinary bladder cancer	0.00119	0.00186	CcSEcCtD
Tiotropium—Paraesthesia—Cisplatin—urinary bladder cancer	0.00119	0.00186	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.00119	0.00186	CcSEcCtD
Tiotropium—Tachycardia—Etoposide—urinary bladder cancer	0.00118	0.00185	CcSEcCtD
Tiotropium—Skin disorder—Etoposide—urinary bladder cancer	0.00118	0.00184	CcSEcCtD
Tiotropium—Dry skin—Doxorubicin—urinary bladder cancer	0.00117	0.00184	CcSEcCtD
Tiotropium—Angina pectoris—Epirubicin—urinary bladder cancer	0.00116	0.00182	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00114	0.00179	CcSEcCtD
Tiotropium—Renal failure—Methotrexate—urinary bladder cancer	0.00112	0.00175	CcSEcCtD
Tiotropium—Dysuria—Epirubicin—urinary bladder cancer	0.00112	0.00175	CcSEcCtD
Tiotropium—Dizziness—Thiotepa—urinary bladder cancer	0.00112	0.00175	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.00111	0.00174	CcSEcCtD
Tiotropium—Stomatitis—Methotrexate—urinary bladder cancer	0.00111	0.00174	CcSEcCtD
Tiotropium—Urticaria—Fluorouracil—urinary bladder cancer	0.00111	0.00174	CcSEcCtD
Tiotropium—Dysphagia—Doxorubicin—urinary bladder cancer	0.00111	0.00173	CcSEcCtD
Tiotropium—Paraesthesia—Etoposide—urinary bladder cancer	0.00109	0.0017	CcSEcCtD
Tiotropium—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.00108	0.00169	CcSEcCtD
Tiotropium—Angina pectoris—Doxorubicin—urinary bladder cancer	0.00108	0.00169	CcSEcCtD
Tiotropium—Epistaxis—Methotrexate—urinary bladder cancer	0.00107	0.00168	CcSEcCtD
Tiotropium—Vomiting—Thiotepa—urinary bladder cancer	0.00107	0.00168	CcSEcCtD
Tiotropium—Rash—Thiotepa—urinary bladder cancer	0.00106	0.00167	CcSEcCtD
Tiotropium—Dermatitis—Thiotepa—urinary bladder cancer	0.00106	0.00166	CcSEcCtD
Tiotropium—Headache—Thiotepa—urinary bladder cancer	0.00106	0.00166	CcSEcCtD
Tiotropium—Renal failure—Epirubicin—urinary bladder cancer	0.00105	0.00164	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00105	0.00164	CcSEcCtD
Tiotropium—Stomatitis—Epirubicin—urinary bladder cancer	0.00104	0.00163	CcSEcCtD
Tiotropium—Constipation—Etoposide—urinary bladder cancer	0.00104	0.00162	CcSEcCtD
Tiotropium—Urinary tract infection—Epirubicin—urinary bladder cancer	0.00104	0.00162	CcSEcCtD
Tiotropium—Dysuria—Doxorubicin—urinary bladder cancer	0.00103	0.00162	CcSEcCtD
Tiotropium—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00103	0.00161	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00103	0.00161	CcSEcCtD
Tiotropium—Pharyngitis—Methotrexate—urinary bladder cancer	0.00101	0.00159	CcSEcCtD
Tiotropium—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00101	0.00158	CcSEcCtD
Tiotropium—Epistaxis—Epirubicin—urinary bladder cancer	0.001	0.00157	CcSEcCtD
Tiotropium—Pruritus—Gemcitabine—urinary bladder cancer	0.001	0.00157	CcSEcCtD
Tiotropium—Nausea—Thiotepa—urinary bladder cancer	0.001	0.00157	CcSEcCtD
Tiotropium—Urethral disorder—Methotrexate—urinary bladder cancer	0.001	0.00157	CcSEcCtD
Tiotropium—Sinusitis—Epirubicin—urinary bladder cancer	0.001	0.00157	CcSEcCtD
Tiotropium—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000997	0.00156	CcSEcCtD
Tiotropium—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000991	0.00155	CcSEcCtD
Tiotropium—Pruritus—Fluorouracil—urinary bladder cancer	0.000988	0.00155	CcSEcCtD
Tiotropium—Visual impairment—Methotrexate—urinary bladder cancer	0.000985	0.00154	CcSEcCtD
Tiotropium—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000975	0.00153	CcSEcCtD
Tiotropium—Renal failure—Doxorubicin—urinary bladder cancer	0.000969	0.00152	CcSEcCtD
Tiotropium—Urticaria—Etoposide—urinary bladder cancer	0.000963	0.00151	CcSEcCtD
Tiotropium—Stomatitis—Doxorubicin—urinary bladder cancer	0.000961	0.0015	CcSEcCtD
Tiotropium—Rhinitis—Epirubicin—urinary bladder cancer	0.000959	0.0015	CcSEcCtD
Tiotropium—Abdominal pain—Etoposide—urinary bladder cancer	0.000958	0.0015	CcSEcCtD
Tiotropium—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000958	0.0015	CcSEcCtD
Tiotropium—Eye disorder—Methotrexate—urinary bladder cancer	0.000955	0.0015	CcSEcCtD
Tiotropium—Pharyngitis—Epirubicin—urinary bladder cancer	0.000949	0.00149	CcSEcCtD
Tiotropium—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000945	0.00148	CcSEcCtD
Tiotropium—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000942	0.00148	CcSEcCtD
Tiotropium—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00094	0.00147	CcSEcCtD
Tiotropium—Urethral disorder—Epirubicin—urinary bladder cancer	0.000938	0.00147	CcSEcCtD
Tiotropium—Epistaxis—Doxorubicin—urinary bladder cancer	0.00093	0.00146	CcSEcCtD
Tiotropium—Angiopathy—Methotrexate—urinary bladder cancer	0.000927	0.00145	CcSEcCtD
Tiotropium—Sinusitis—Doxorubicin—urinary bladder cancer	0.000925	0.00145	CcSEcCtD
Tiotropium—Immune system disorder—Methotrexate—urinary bladder cancer	0.000923	0.00145	CcSEcCtD
Tiotropium—Dizziness—Fluorouracil—urinary bladder cancer	0.000923	0.00145	CcSEcCtD
Tiotropium—Visual impairment—Epirubicin—urinary bladder cancer	0.000922	0.00144	CcSEcCtD
Tiotropium—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000921	0.00144	CcSEcCtD
Tiotropium—Vomiting—Gemcitabine—urinary bladder cancer	0.000903	0.00141	CcSEcCtD
Tiotropium—Mental disorder—Methotrexate—urinary bladder cancer	0.000895	0.0014	CcSEcCtD
Tiotropium—Rash—Gemcitabine—urinary bladder cancer	0.000895	0.0014	CcSEcCtD
Tiotropium—Dermatitis—Gemcitabine—urinary bladder cancer	0.000894	0.0014	CcSEcCtD
Tiotropium—Eye disorder—Epirubicin—urinary bladder cancer	0.000894	0.0014	CcSEcCtD
Tiotropium—Hypersensitivity—Etoposide—urinary bladder cancer	0.000893	0.0014	CcSEcCtD
Tiotropium—Malnutrition—Methotrexate—urinary bladder cancer	0.00089	0.00139	CcSEcCtD
Tiotropium—Headache—Gemcitabine—urinary bladder cancer	0.000889	0.00139	CcSEcCtD
Tiotropium—Vomiting—Fluorouracil—urinary bladder cancer	0.000887	0.00139	CcSEcCtD
Tiotropium—Rhinitis—Doxorubicin—urinary bladder cancer	0.000887	0.00139	CcSEcCtD
Tiotropium—Rash—Fluorouracil—urinary bladder cancer	0.00088	0.00138	CcSEcCtD
Tiotropium—Dermatitis—Fluorouracil—urinary bladder cancer	0.000879	0.00138	CcSEcCtD
Tiotropium—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000878	0.00138	CcSEcCtD
Tiotropium—Headache—Fluorouracil—urinary bladder cancer	0.000874	0.00137	CcSEcCtD
Tiotropium—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000874	0.00137	CcSEcCtD
Tiotropium—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000872	0.00137	CcSEcCtD
Tiotropium—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00087	0.00136	CcSEcCtD
Tiotropium—Angiopathy—Epirubicin—urinary bladder cancer	0.000868	0.00136	CcSEcCtD
Tiotropium—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000867	0.00136	CcSEcCtD
Tiotropium—Immune system disorder—Epirubicin—urinary bladder cancer	0.000864	0.00135	CcSEcCtD
Tiotropium—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000862	0.00135	CcSEcCtD
Tiotropium—Back pain—Methotrexate—urinary bladder cancer	0.000861	0.00135	CcSEcCtD
Tiotropium—Pruritus—Etoposide—urinary bladder cancer	0.000858	0.00134	CcSEcCtD
Tiotropium—Arrhythmia—Epirubicin—urinary bladder cancer	0.000854	0.00134	CcSEcCtD
Tiotropium—Visual impairment—Doxorubicin—urinary bladder cancer	0.000853	0.00134	CcSEcCtD
Tiotropium—Nausea—Gemcitabine—urinary bladder cancer	0.000843	0.00132	CcSEcCtD
Tiotropium—Vomiting—Cisplatin—urinary bladder cancer	0.000841	0.00132	CcSEcCtD
Tiotropium—Vision blurred—Methotrexate—urinary bladder cancer	0.000838	0.00131	CcSEcCtD
Tiotropium—Mental disorder—Epirubicin—urinary bladder cancer	0.000838	0.00131	CcSEcCtD
Tiotropium—Rash—Cisplatin—urinary bladder cancer	0.000834	0.00131	CcSEcCtD
Tiotropium—Dermatitis—Cisplatin—urinary bladder cancer	0.000834	0.00131	CcSEcCtD
Tiotropium—Malnutrition—Epirubicin—urinary bladder cancer	0.000833	0.0013	CcSEcCtD
Tiotropium—Nausea—Fluorouracil—urinary bladder cancer	0.000829	0.0013	CcSEcCtD
Tiotropium—Eye disorder—Doxorubicin—urinary bladder cancer	0.000827	0.00129	CcSEcCtD
Tiotropium—Back pain—Epirubicin—urinary bladder cancer	0.000805	0.00126	CcSEcCtD
Tiotropium—Angiopathy—Doxorubicin—urinary bladder cancer	0.000803	0.00126	CcSEcCtD
Tiotropium—Dizziness—Etoposide—urinary bladder cancer	0.000802	0.00126	CcSEcCtD
Tiotropium—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000799	0.00125	CcSEcCtD
Tiotropium—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000798	0.00125	CcSEcCtD
Tiotropium—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000791	0.00124	CcSEcCtD
Tiotropium—Nausea—Cisplatin—urinary bladder cancer	0.000786	0.00123	CcSEcCtD
Tiotropium—Vision blurred—Epirubicin—urinary bladder cancer	0.000785	0.00123	CcSEcCtD
Tiotropium—Cough—Methotrexate—urinary bladder cancer	0.000776	0.00122	CcSEcCtD
Tiotropium—Mental disorder—Doxorubicin—urinary bladder cancer	0.000775	0.00121	CcSEcCtD
Tiotropium—Vomiting—Etoposide—urinary bladder cancer	0.000771	0.00121	CcSEcCtD
Tiotropium—Malnutrition—Doxorubicin—urinary bladder cancer	0.00077	0.00121	CcSEcCtD
Tiotropium—Rash—Etoposide—urinary bladder cancer	0.000764	0.0012	CcSEcCtD
Tiotropium—Dermatitis—Etoposide—urinary bladder cancer	0.000764	0.0012	CcSEcCtD
Tiotropium—Headache—Etoposide—urinary bladder cancer	0.000759	0.00119	CcSEcCtD
Tiotropium—Myalgia—Methotrexate—urinary bladder cancer	0.000757	0.00119	CcSEcCtD
Tiotropium—Arthralgia—Methotrexate—urinary bladder cancer	0.000757	0.00119	CcSEcCtD
Tiotropium—Chest pain—Methotrexate—urinary bladder cancer	0.000757	0.00119	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000752	0.00118	CcSEcCtD
Tiotropium—Syncope—Epirubicin—urinary bladder cancer	0.000747	0.00117	CcSEcCtD
Tiotropium—Back pain—Doxorubicin—urinary bladder cancer	0.000745	0.00117	CcSEcCtD
Tiotropium—Palpitations—Epirubicin—urinary bladder cancer	0.000736	0.00115	CcSEcCtD
Tiotropium—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000732	0.00115	CcSEcCtD
Tiotropium—Cough—Epirubicin—urinary bladder cancer	0.000727	0.00114	CcSEcCtD
Tiotropium—Vision blurred—Doxorubicin—urinary bladder cancer	0.000726	0.00114	CcSEcCtD
Tiotropium—Infection—Methotrexate—urinary bladder cancer	0.000721	0.00113	CcSEcCtD
Tiotropium—Nausea—Etoposide—urinary bladder cancer	0.00072	0.00113	CcSEcCtD
Tiotropium—Hypertension—Epirubicin—urinary bladder cancer	0.000719	0.00113	CcSEcCtD
Tiotropium—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000712	0.00111	CcSEcCtD
Tiotropium—Arthralgia—Epirubicin—urinary bladder cancer	0.000709	0.00111	CcSEcCtD
Tiotropium—Chest pain—Epirubicin—urinary bladder cancer	0.000709	0.00111	CcSEcCtD
Tiotropium—Myalgia—Epirubicin—urinary bladder cancer	0.000709	0.00111	CcSEcCtD
Tiotropium—Skin disorder—Methotrexate—urinary bladder cancer	0.000705	0.0011	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000704	0.0011	CcSEcCtD
Tiotropium—Dry mouth—Epirubicin—urinary bladder cancer	0.000693	0.00109	CcSEcCtD
Tiotropium—Syncope—Doxorubicin—urinary bladder cancer	0.000691	0.00108	CcSEcCtD
Tiotropium—Palpitations—Doxorubicin—urinary bladder cancer	0.000681	0.00107	CcSEcCtD
Tiotropium—Oedema—Epirubicin—urinary bladder cancer	0.00068	0.00106	CcSEcCtD
Tiotropium—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000677	0.00106	CcSEcCtD
Tiotropium—Infection—Epirubicin—urinary bladder cancer	0.000675	0.00106	CcSEcCtD
Tiotropium—Cough—Doxorubicin—urinary bladder cancer	0.000672	0.00105	CcSEcCtD
Tiotropium—Shock—Epirubicin—urinary bladder cancer	0.000669	0.00105	CcSEcCtD
Tiotropium—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000666	0.00104	CcSEcCtD
Tiotropium—Hypertension—Doxorubicin—urinary bladder cancer	0.000665	0.00104	CcSEcCtD
Tiotropium—Tachycardia—Epirubicin—urinary bladder cancer	0.000663	0.00104	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000662	0.00104	CcSEcCtD
Tiotropium—Skin disorder—Epirubicin—urinary bladder cancer	0.00066	0.00103	CcSEcCtD
Tiotropium—Insomnia—Methotrexate—urinary bladder cancer	0.000657	0.00103	CcSEcCtD
Tiotropium—Chest pain—Doxorubicin—urinary bladder cancer	0.000656	0.00103	CcSEcCtD
Tiotropium—Myalgia—Doxorubicin—urinary bladder cancer	0.000656	0.00103	CcSEcCtD
Tiotropium—Arthralgia—Doxorubicin—urinary bladder cancer	0.000656	0.00103	CcSEcCtD
Tiotropium—Paraesthesia—Methotrexate—urinary bladder cancer	0.000652	0.00102	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000651	0.00102	CcSEcCtD
Tiotropium—Dry mouth—Doxorubicin—urinary bladder cancer	0.000641	0.001	CcSEcCtD
Tiotropium—Dyspepsia—Methotrexate—urinary bladder cancer	0.000639	0.001	CcSEcCtD
Tiotropium—Oedema—Doxorubicin—urinary bladder cancer	0.000629	0.000984	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000627	0.000982	CcSEcCtD
Tiotropium—Infection—Doxorubicin—urinary bladder cancer	0.000625	0.000978	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000619	0.000969	CcSEcCtD
Tiotropium—Shock—Doxorubicin—urinary bladder cancer	0.000619	0.000969	CcSEcCtD
Tiotropium—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000617	0.000965	CcSEcCtD
Tiotropium—Insomnia—Epirubicin—urinary bladder cancer	0.000615	0.000962	CcSEcCtD
Tiotropium—Tachycardia—Doxorubicin—urinary bladder cancer	0.000614	0.000961	CcSEcCtD
Tiotropium—Skin disorder—Doxorubicin—urinary bladder cancer	0.000611	0.000956	CcSEcCtD
Tiotropium—Paraesthesia—Epirubicin—urinary bladder cancer	0.00061	0.000955	CcSEcCtD
Tiotropium—Dyspepsia—Epirubicin—urinary bladder cancer	0.000598	0.000937	CcSEcCtD
Tiotropium—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000594	0.00093	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000587	0.000919	CcSEcCtD
Tiotropium—Constipation—Epirubicin—urinary bladder cancer	0.000581	0.00091	CcSEcCtD
Tiotropium—Urticaria—Methotrexate—urinary bladder cancer	0.000577	0.000903	CcSEcCtD
Tiotropium—Abdominal pain—Methotrexate—urinary bladder cancer	0.000574	0.000899	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000573	0.000897	CcSEcCtD
Tiotropium—Insomnia—Doxorubicin—urinary bladder cancer	0.000569	0.00089	CcSEcCtD
Tiotropium—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000565	0.000884	CcSEcCtD
Tiotropium—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000556	0.00087	CcSEcCtD
Tiotropium—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000553	0.000867	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000543	0.00085	CcSEcCtD
Tiotropium—Urticaria—Epirubicin—urinary bladder cancer	0.00054	0.000845	CcSEcCtD
Tiotropium—Constipation—Doxorubicin—urinary bladder cancer	0.000538	0.000842	CcSEcCtD
Tiotropium—Abdominal pain—Epirubicin—urinary bladder cancer	0.000537	0.000841	CcSEcCtD
Tiotropium—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000535	0.000838	CcSEcCtD
Tiotropium—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000514	0.000805	CcSEcCtD
Tiotropium—Pruritus—Methotrexate—urinary bladder cancer	0.000514	0.000804	CcSEcCtD
Tiotropium—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000501	0.000784	CcSEcCtD
Tiotropium—Urticaria—Doxorubicin—urinary bladder cancer	0.000499	0.000782	CcSEcCtD
Tiotropium—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000497	0.000778	CcSEcCtD
Tiotropium—Pruritus—Epirubicin—urinary bladder cancer	0.000481	0.000753	CcSEcCtD
Tiotropium—Dizziness—Methotrexate—urinary bladder cancer	0.00048	0.000752	CcSEcCtD
Tiotropium—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000463	0.000725	CcSEcCtD
Tiotropium—Vomiting—Methotrexate—urinary bladder cancer	0.000462	0.000723	CcSEcCtD
Tiotropium—Rash—Methotrexate—urinary bladder cancer	0.000458	0.000717	CcSEcCtD
Tiotropium—Dermatitis—Methotrexate—urinary bladder cancer	0.000457	0.000716	CcSEcCtD
Tiotropium—Headache—Methotrexate—urinary bladder cancer	0.000455	0.000712	CcSEcCtD
Tiotropium—Dizziness—Epirubicin—urinary bladder cancer	0.000449	0.000704	CcSEcCtD
Tiotropium—Pruritus—Doxorubicin—urinary bladder cancer	0.000445	0.000697	CcSEcCtD
Tiotropium—Vomiting—Epirubicin—urinary bladder cancer	0.000432	0.000676	CcSEcCtD
Tiotropium—Nausea—Methotrexate—urinary bladder cancer	0.000431	0.000675	CcSEcCtD
Tiotropium—Rash—Epirubicin—urinary bladder cancer	0.000428	0.000671	CcSEcCtD
Tiotropium—Dermatitis—Epirubicin—urinary bladder cancer	0.000428	0.00067	CcSEcCtD
Tiotropium—Headache—Epirubicin—urinary bladder cancer	0.000426	0.000667	CcSEcCtD
Tiotropium—Dizziness—Doxorubicin—urinary bladder cancer	0.000416	0.000651	CcSEcCtD
Tiotropium—Nausea—Epirubicin—urinary bladder cancer	0.000404	0.000632	CcSEcCtD
Tiotropium—Vomiting—Doxorubicin—urinary bladder cancer	0.0004	0.000626	CcSEcCtD
Tiotropium—Rash—Doxorubicin—urinary bladder cancer	0.000396	0.000621	CcSEcCtD
Tiotropium—Dermatitis—Doxorubicin—urinary bladder cancer	0.000396	0.00062	CcSEcCtD
Tiotropium—Headache—Doxorubicin—urinary bladder cancer	0.000394	0.000617	CcSEcCtD
Tiotropium—Nausea—Doxorubicin—urinary bladder cancer	0.000373	0.000585	CcSEcCtD
